TRIB

Trinity Biotech
TRIB

Overview Fund Trends Analyst Outlook Journalist POV

20 hedge funds and large institutions have $4.49M invested in Trinity Biotech in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

24% less capital invested

Capital invested by funds: $5.93M → $4.49M (-$1.43M)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $13K

Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$13K
Net Calls
Net Calls Change

Top Buyers

1
+$6.12K
2
+$104

Top Sellers

1
-$36.3K
2
-$17.4K
3
-$7.06K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$3.21K
5
RWMG
Redwood Wealth Management Group
New Jersey
-$221
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.26M
2
$1.11M
3
$1M
4
$526K
5
$301K
6
$119K
7
$82K
8
$22.2K
9
$19.7K
10
$12.2K
11
$12.2K
12
$10.7K
13
$7.35K
14
$1.35K
15
$1.1K
16
$885
17
$715
18
$104
19
$74
20
$3
21
–